Business · 01/05/2023
FDA Releases Final Guidance on Nonclinical Biodistribution Studies for Gene Therapy Products
The FDA has released a final guidance for the pharmaceutical industry on nonclinical biodistribution studies for gene therapy products, aiming to reduce animal use while developing investigational products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →